Two recent announcements have put Delta-like ligand 3 (DLL3), a high-potential target, into the spotlight. Both Hengrui Pharma and Innovent's ADC innovative drugs were licensed out for more than US$1 billion. DLL3Antibody–drug conjugates or ADCs are a class of biopharmaceutical drugs design
Photo: TP-LINKOn December 18th 2024, The Wall Street Journal reported that the US government is studying the possibility of banning Chinese network router companies from selling TP-Link products in the US for fear that TP-Link might be involved in cyber-attacks by Chinese hackers
Huawei gained an injunction against Netgear in seven countries in EU.
Gree revealed that it had received a compensation of 500,000 yuan from Xiaomi for infringing its air conditioner patent.
Japanese electronic components manufacturer Murata has initiated patent enforcement action against another of its Chinese competitors, as per an announcement made by the China National Intellectual Property Administration(CNIPA).
